Caffeic Acid

Caffeic Acid

SCHEMBL23358

O=C(O)/C=C/c1ccc(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 1.00
HSD17B10 Q99714 3/20 1.00
CA12 O43570 3/20 1.00
CA1 P00915 3/20 1.00
CA2 P00918 3/20 1.00
CA3 P07451 3/20 1.00
CA4 P22748 3/20 1.00
CA6 P23280 3/20 1.00
CA5A P35218 3/20 1.00
CA7 P43166 3/20 1.00
CA9 Q16790 3/20 1.00
CA14 Q9ULX7 3/20 1.00
CA5B Q9Y2D0 3/20 1.00
MAPT P10636 2/20 1.00
TTR P02766 2/20 1.00
APP P05067 2/20 1.00
AKR1B10 O60218 2/20 1.00
AKR1B1 P15121 2/20 1.00
DPP4 P27487 2/20 1.00
MMP1 P03956 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Caffeic Acid SCHEMBL23359 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL30501140 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL29447135 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL30050844 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL29353048 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL3682144 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL7064846 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL1262229 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL21114743 1.00 KDM4E (1.00) KDM4EHSD17B10CA12CA1CA2
Caffeic Acid SCHEMBL9477189 0.98 KDM4E (0.96) KDM4EHSD17B10CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 45697 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122075420-A Imidazo [1,2-a ] pyridine derivative pharmaceutical composition and application thereof 2026-05-26 CN claimed
CN-122084784-A Multivariable near-infrared quantitative model based on one-measurement-multiple-evaluation-method calibration, construction method and application thereof 2026-05-26 CN claimed
CN-121321258-B Multifunctional cellulose-based fiber and preparation method thereof QINGDAO UNIVERSITY (CN) 2026-05-26 CN claimed
US-12636311-B2 Topically administered strontium-containing complexes for treating pain, pruritis and inflammation GALLEON LABS LLC (US) 2026-05-26 US claimed
US-12637656-B2 Recombinant yeast capable of producing caffeic acid and/or ferulic acid ABOLIS BIOTECHNOLOGIES (FR) 2026-05-26 US claimed
CN-122080390-A Special efficient air entraining agent for aluminoferrite cement and preparation method thereof 2026-05-26 CN claimed
CN-122080255-A Chitosan-organic acid supermolecule ionic salt and preparation method thereof 2026-05-26 CN claimed
CN-122074583-A Method for synergistically improving emulsion stability of soybean protein concentrate based on double modification of starch-based oligosaccharide and phenolic acid 2026-05-26 CN claimed
CN-122071832-A Polyethylene non-woven fabric and preparation method, preparation device and application thereof 中国石油化工股份有限公司 2026-05-22 CN claimed
WO-2026107510-A1 HOT-MELT ADHESIVE COMPOSITION AND METHOD OF APPLICATION BIOBOND ADHESIVES, INC. (US) 2026-05-21 WO claimed
US-4297125-A Tree rooting using synthetic auxins THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1981-10-27 US claimed
EP-0036534-A1 An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-30 EP claimed
EP-0036145-A1 An orally administered drug form comprising a polar bioactive agent and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-23 EP claimed
EP-0035770-A2 An orally administered drug form comprising a glycosidic antibiotic and an adjuvant INTERx RESEARCH CORPORATION (US) 1981-09-16 EP claimed
EP-0031561-A2 A rectally administered suppository comprising a drug and an adjuvant MERCK & CO. INC. (US) 1981-07-08 EP claimed
US-4212799-A Method for preparing a proteinic isolate from sunflowerseed meal using aluminum salts SNAM PROGETTI, S.P.A. (IT) 1980-07-15 US claimed
US-4144133-A OXGALL, SAPONIN, SUBSTRATE FOR PHENOL OXIDASE J. K. AND SUSIE L. WADLEY RESEARCH INSTITUTE AND BLOOD BANK (US) 1979-03-13 US claimed
US-4124724-A Crystalline caffeic acid derivatives and compositions and method for treating snakebite AGORO JOHN W 1978-11-07 US claimed
US-3970459-A Process for developing a direct reversal silver halide photographic light-sensitive material FUJI PHOTO FILM CO., LTD. (JA) 1976-07-20 US claimed
US-3965033-A Process for the production of oil-containing microcapsules FUJI PHOTO FILM CO., LTD. (JA) 1976-06-22 US claimed